Anne Hale, DVM

Chief Technical Officer

Anne Hale is a renowned expert in veterinary transfusion medicine. Dr. Hale has a strong academic track record and has received a NIH Comparative Fellowship in Transfusion Medicine. Dr. Hale founded and guided Midwest Animal Blood Services, an internationally known blood bank.  She worked as the CEO and Director for Animal Blood Resources International while the company launched a new line of lyophilized blood products. Dr. Hale is currently CSO of The Platelet Farm, managing the research and commercialization of veterinary blood products (included freeze-dried equine platelet lysate). In addition, Dr. Hale held a position as an internist at the Veterinary Emergency and Specialist Centers in New Mexico before joining BodeVet. Dr. Hale is a founding member of the American Association of Veterinary Blood Banks, and is an active member of many other like organizations including the American Veterinary Medical Association, the North American Veterinary Regenerative Medicine Association, and the Association of Veterinary Hematology and Transfusion Medicine. Dr. Hale is also a trustee for The Pet Blood Bank UK.

Robert Woods

Operations Manager

Robert Woods joins BodeVet with experience from serving as the Operations Manager for Cellphire, Inc. He controls all of Cellphire’s human resources, information technology, exposure control plan, corporate equity, and facilities operations. Robert Woods first joined Cellphire to assist in the implementation of government contracts after having managed government contracts with Holloway & Co. using a custom data repository. Previously, Robert Woods worked as a Transportation Broker for MegaCorp Logistics, and was part of the leading sales team for their logistics division for two years. Robert Woods holds a BA from the University of North Carolina Wilmington in Business Management and Communication Studies. He is currently pursuing Executive Leadership and Human Resource Management at Cornell University.

Jessica (Jessie) Brown

Clinical Coordinator & Lead Apheresis Technician

Jessie brings over 15 years of veterinary technical experience in specialty and emergency clinics, plus management and operational experience in creating and running a regional veterinary blood bank. Her hands-on skills and understanding of the needs for blood and blood products in veterinary practice enhance the technical capabilities of BodeVet. Jessie holds a bachelor’s degree from the University of South Carolina, and has research experience with dogs and sea turtles.

Tracy Gross

Customer Service Representative

Tracy Gross brings more than a decade of experience in customer relations, management, and operations to BodeVet. While serving as a Branch Manager at PNC Bank and Bank of America, Tracy Gross led and offered management training to teams of over 15 associates to effect in achieving branch goals. At PNC Bank, Ms. Gross exceeded monthly goals. Ms. Gross developed and enforced rigorous customer service standards which emphasized providing specific attention and detail to customers on an individual basis.

Board of Directors

Stephen Willard


read more

Stephen Willard is the CEO of Cellphire, Inc. He was previously the CEO of Flamel Technologies, a NASDAQ-traded biotechnology company, for seven years and served as CFO prior to becoming CEO. He was the former Chairman of the Board of Directors of Flamel Technolgies and also served on the Board of Directors of E-Trade Financial Corporation. Stephen Willard holds a BA from Williams College and a JD from Yale Law School.

John Michael Preston BVMS, PhD, DVMS, MRCVS


read more

Professor Preston obtained his veterinary degree from the University of Glasgow, Scotland, followed by a PhD from the London School of Hygiene and Tropical Medicine. After six years in Kenya’s Veterinary Research Laboratories he joined Merck & Co.’s Animal Science Research laboratories in Europe. In 1987 he moved to the US where he assumed worldwide responsibility for animal health clinical research and development. Four years later he transferred to Merck AgVet, Merck’s animal health and agriculture division, becoming President and joining the Management Committee of Merck & Co. Inc. two years later. In 1997, as founding Executive Chairman of Merial, he led the merger of the animal health and poultry genetics assets of Merck and Co. Inc. and Rhône Poulenc to form the world’s leading animal health company with an initial annual turnover of $1.8bn. John is an honorary professor in the University of Glasgow Veterinary School and has sat on the boards of a number of companies, foundations and UK government agencies, including the Veterinary Medicines Directorate and the Animal Health Veterinary Laboratories Agency.

Rafael Jorda


read more

Rafael Jorda is an international scientific leader with more than 25 years of experience in private and public company management spanning 3 continents. Specifically, Rafael Jorda has managed the Research and Development, Intellectual Property, Production, and Business Development operations of pharmaceutical and biotechnology companies. Rafael is a co-founder of Flamel Technologies (FLML) and, leading its research and manufacturing departments, built Flamel into a public company. Previously, Rafael worked in the polymer research group of Rhône-Poulenc. Rafael holds a Masters of Science in Chemical Engineering from Virginia Polytechnic Institute and State University.

Nigel J. McWilliam

Company Secretary

read more

Nigel also serves as the Vice President of Business Development for Cellphire. Previously, he was the Vice President of Business Development for Flamel Technologies (FLML). From 1999 to 2003 he established a business development group in the United States and Japan for SkyePharma as their Senior Vice President of Business Development. His career began with 18 years at Dow Corning Corporation in commercial roles serving their health care businesses in the United Kingdom, Belgium, and France before moving to their headquarters in Midland, MI in 1988. He is a graduate of the Dundee University, Scotland, with a BSc in Physiology and Psychology.

Scientific Advisory Board

Dana LeVine, DVM, PhD, DACVIM


read more

Dana LeVine specializes in small animal internal medicine with a special interest in hematology.  Her research focuses on disorders of hyper- and hypocoagulability, especially immune thrombocytopenia (ITP).  She also studies neutrophil extracellular traps (NETs) and their role in thrombosis in dogs.    

G. Michael Fitzpatrick, PhD


read more

Dr. Fitzpatrick has worked at Cellphire since 2007 and serves as the Company’s President. He led R&D efforts to develop clinical applications for its first line of products. Dr. Fitzpatrick previously worked at America’s Blood Centers as Chief Operating Officer, prior to that he was a Colonel in the US Army and the Director of the Armed Services Blood Program Office.